PolyPeptide Group makes peptide-based active pharmaceutical ingredients for pharmaceutical and biotechnology companies. It supplies custom and generic peptides used in medicines, serving customers that develop and manufacture drug products. The company operates manufacturing sites in Europe and North America and is based in Zug, Switzerland. Its work covers the chemical synthesis of peptides at scales ranging from research quantities to commercial production, and it also offers related analytical and regulatory support to its pharmaceutical clients.
PolyPeptide Group AG trades under the code 0AAJ on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #680 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
82/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average18.5%
From 52-week high-10.7%
MomentumStrong
79/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return0.6%
6-month return26.7%
12-month, skipping last month78.2%
Stability (higher is calmer)Weak
48/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)43.1%
Worst drawdown, 1 year (smaller is calmer)-24.9%
LiquidityFair
59/100
Moderate trading activity.
See the numbers →
Avg daily value traded1.76M GBP
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends1
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 21.95 – 50.00Daily closes, split-adjusted
Signals
50-day average44.03
200-day average37.18
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.15
Technical summary
Daily
Strongly bullish
10 bullish · 5 neutral · 1 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
44.05
Bearish
EMA 10
44.04
Bullish
SMA 20
44.05
Bullish
EMA 20
44.04
Bullish
SMA 50
44.03
Bullish
EMA 50
43.85
Bullish
SMA 100
43.40
Bullish
EMA 100
42.29
Bullish
SMA 200
37.18
Bullish
EMA 200
38.40
Bullish
Oscillators (daily)
RSI (14)
50.54
Neutral
MACD (12, 26)
0.00
Bullish
Momentum (12)
0.00
Neutral
Stochastic %K (14)
54.55
Neutral
Williams %R (14)
-45.45
Neutral
CCI (20)
45.23
Neutral
Pivot points (classic, last session)
S3
43.85
S2
43.95
S1
44.00
Pivot
44.10
R1
44.15
R2
44.25
R3
44.30
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 GBX
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.0030
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in GBP. Educational only, not financial advice.
